8-K - Amylyx Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On November 6, 2025, Amylyx Pharmaceuticals, Inc. (the “Company”) issued a press release announcing its financial

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 99.1 Press Release of the Company, dated November 6, 2025 104 Cover Page Interactiv

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1